These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28658154)

  • 1. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
    Ashton JJ; Colquhoun CM; Cleary DW; Coelho T; Haggarty R; Mulder I; Batra A; Afzal NA; Beattie RM; Scott KP; Ennis S
    Medicine (Baltimore); 2017 Jun; 96(26):e7347. PubMed ID: 28658154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
    Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M; Nam S
    BMC Microbiol; 2024 Jul; 24(1):268. PubMed ID: 39030520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease.
    Lemay JA; Yamamoto M; Kroezen Z; Shanmuganathan M; Ly R; Hart L; Pai N; Britz-McKibbin P
    J Pharm Biomed Anal; 2021 Jan; 192():113658. PubMed ID: 33091761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
    Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
    Schierova D; Roubalova R; Kolar M; Stehlikova Z; Rob F; Jackova Z; Coufal S; Thon T; Mihula M; Modrak M; Kverka M; Bajer L; Kostovcikova K; Drastich P; Hercogova J; Novakova M; Vasatko M; Lukas M; Tlaskalova-Hogenova H; Jiraskova Zakostelska Z
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
    Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure.
    Sze MA; Topçuoğlu BD; Lesniak NA; Ruffin MT; Schloss PD
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child.
    Wijeyesekera A; Wagner J; De Goffau M; Thurston S; Rodrigues Sabino A; Zaher S; White D; Ridout J; Peters MJ; Ramnarayan P; Branco RG; Torok ME; Valla F; Meyer R; Klein N; Frost G; Parkhill J; Holmes E; Pathan N
    Crit Care Med; 2019 Sep; 47(9):e727-e734. PubMed ID: 31169619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.